Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia
Front Pharmacol. 2024 Nov 14;15:1480657. doi: 10.3389/fphar.2024.1480657. eCollection 2024. ABSTRACT BACKGROUND: Methotrexate (MTX) is the primary drug used in the treatment of pediatric acute lymphoblastic …